Literature DB >> 23578712

Structural and functional mosaic nature of MHC class I molecules in their peptide-free form.

Eiji Kurimoto1, Kimiko Kuroki, Yoshiki Yamaguchi, Maho Yagi-Utsumi, Takahiro Igaki, Takeshi Iguchi, Katsumi Maenaka, Koichi Kato.   

Abstract

Despite well-organized peptide-loading mechanisms within the endoplasmic reticulum, major histocompatibility complex class I (MHC-I) molecules can be displayed on cell surfaces in peptide-free forms. Although these empty MHC-I (eMHC-I) molecules are presumably involved in physiological and pathological processes, little is known about their structures and functions due to their instability. Using bacterially expressed HLA-Cw*07:02 heavy chain and β2 microglobulin molecules, we successfully established an in vitro refolding method to prepare eMHC-I molecules in sufficient quantities for detailed structural analyses. NMR spectroscopy in conjunction with subunit-specific ¹⁵N-labeling techniques revealed that the peptide-binding domains and the adjacent regions were unstructured in the peptide-free form, while the remaining regions maintained their structural integrity. Consistent with our spectroscopic data, the eMHC-I complex could interact with leukocyte Ig-like receptor B1, but not with killer cell Ig-like receptor 2DL3. Thus, eMHC-I molecules have a mosaic nature in terms of their three-dimensional structure and binding to immunologically relevant molecules.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578712     DOI: 10.1016/j.molimm.2013.03.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.

Authors:  Vadim Jucaud; Mepur H Ravindranath; Paul I Terasaki
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Dipeptides promote folding and peptide binding of MHC class I molecules.

Authors:  Sunil Kumar Saini; Katja Ostermeir; Venkat Raman Ramnarayan; Heiko Schuster; Martin Zacharias; Sebastian Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

3.  TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.

Authors:  Andrew C McShan; Christine A Devlin; Georgia F Papadaki; Yi Sun; Adam I Green; Giora I Morozov; George M Burslem; Erik Procko; Nikolaos G Sgourakis
Journal:  Nat Chem Biol       Date:  2022-06-20       Impact factor: 16.174

Review 4.  Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface.

Authors:  Fernando M Ruggiero; Sebastian Springer
Journal:  Curr Res Immunol       Date:  2022-05-23

Review 5.  Dynamics of MHC-I molecules in the antigen processing and presentation pathway.

Authors:  Hau V Truong; Nikolaos G Sgourakis
Journal:  Curr Opin Immunol       Date:  2021-06-18       Impact factor: 7.268

6.  The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.

Authors:  Esam Tolba Abualrous; Sunil Kumar Saini; Venkat Raman Ramnarayan; Florin Tudor Ilca; Martin Zacharias; Sebastian Springer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 7.  Proofreading of Peptide-MHC Complexes through Dynamic Multivalent Interactions.

Authors:  Christoph Thomas; Robert Tampé
Journal:  Front Immunol       Date:  2017-02-08       Impact factor: 7.561

8.  Direct evidence for conformational dynamics in major histocompatibility complex class I molecules.

Authors:  Andy van Hateren; Malcolm Anderson; Alistair Bailey; Jörn M Werner; Paul Skipp; Tim Elliott
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

Review 9.  Peptide and Peptide-Dependent Motions in MHC Proteins: Immunological Implications and Biophysical Underpinnings.

Authors:  Cory M Ayres; Steven A Corcelli; Brian M Baker
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

Review 10.  Exploration of the Conformational Dynamics of Major Histocompatibility Complex Molecules.

Authors:  Saeko Yanaka; Kenji Sugase
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.